Omeprazolo Teva Italia (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Teva Italia, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Omeprazolo Teva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazolo Teva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid‑secretion pathway by inhibiting the hydrogen‑potassium ATP‑ase pump. It provides symptom relief and healing in several acid‑related disorders:

- Gastro‑esophageal reflux disease (GERD): reduces heartburn and promotes esophageal healing. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens (as adjunct): enhances effectiveness of antibiotic therapy. - NSA‑induced gastropathy (prevention): lowers risk of ulcer formation in high‑risk patients.

Omeprazole is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: - Headache : m mild mild but often trans‑ t   -   -   -  -  - 

Serious or Rare Side Effects: -  t   t  t  t. -  t. -  t. -  t. -  t. -  t. -  -  t. -  t. -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - """

The ... 

"